Republicans, who had opposed the stimulus, said the packagehad failed to stop the rising jobless rate and Democrats led byVice President Joe Biden insisted it needs more time to work. With $749 million in assets, it has aunique position in the marketplace today as an independent, local andentrepreneurial provider of financial services, specializing in services andsolutions that help family-owned businesses compete and grow. Seattle Bank hasfive banking centers in the Puget Sound area and its affiliated companiesinclude Seattle Escrow and Seattle Mortgage. Seattle BankMary Grace Roske, 206-273-7359 (Work)206-235-8518 (Cell)Copyright Business Wire 2009. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Neuropathic Pain: Treatments and PrescribingPractices – A Global Survey 2009″ report to their offering. With estimated prevalence levels of 3-10%, the treatment of Neuropathic Pain(NP) remains an area of significant unmet need. NP is highly individual in itspresentation, level, underlying pathology and response to therapy.

For somepatients, available therapies give satisfactory pain control For many others,treatments are poor or do not work at all. Therapeutic options include more thanten drug classes, which are commonly prescribed in combinations tailored toindividual patient needs. Interventional treatments, such as peripheral nerve block and transcutaneouselectrical nerve stimulation, are also used as physicians seek other approachesto treating NP. This background, the individual nature of NP and the drug (ordrug combination) options used to treat patients, has created a complextherapeutic picture. In a therapeutic field where treatments are often unsatisfactory, physiciansseek to extent their understanding of NP in an effort to define needs andlimitations. Knowledge in these areas is also important to drug developers, whoseek a better understanding of patient needs and outcomes, as part of their ownefforts to develop more effective therapies.

To meet interest in these areas,Biopharm Reports has conducted an in-depth global survey on current treatmentsand drug prescribing practices, relating to NP. This survey involved theparticipation of more than 330 physicians and clinical centres in 56 countries. Overview: Comprehensive details of current treatments for NP, provided by more than 330clinics in 56 countries. In-depth information relevant to markets and opportunities in the NP field. 98% of participants are practicing physicians, working in specialised areas ofpain treatment.